Significant Ownership of 1Globe Capital LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for 1Globe Capital LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Jiaqiang Li - Chairman
- Manager location
- Boston, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow 1Globe Capital LLC and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from 1Globe Capital LLC
Significant Ownership of 1Globe Capital LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SVA | SINOVAC BIOTECH LTD | Common Shares, par value $0.001 per share | 32% | 18,515,315 | 0% | 1Globe Capital LLC | 07 Jul 2025 | ||
| CBIO | Crescent Biopharma, Inc. | Ordinary Shares, par value $0.001 per share | 10% | $20,839,816 | +$7,729,886 | 1,425,432 | +59% | 1Globe Capital LLC | 07 Oct 2025 |
Schedules 13D/G Reported by 1Globe Capital LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.